Bacterial Vaginosis Global Market Report 2025

Description

Bacterial vaginosis (BV) is a prevalent vaginal infection resulting from an imbalance in naturally occurring bacteria. This imbalance leads to a reduction in lactobacilli and an overgrowth of anaerobic bacteria. Common symptoms include a fishy odor, thin grayish-white discharge, and vaginal discomfort, though some cases may be asymptomatic.

The primary categories of bacterial vaginosis include point-of-care testing, laboratory testing, and others. Point-of-care testing (POCT) involves medical diagnostic tests conducted at or near the patient's location, delivering rapid results for immediate clinical decision-making. Various product categories include those designed for individuals under 15 years, those aged 15-45 years, and others. Applications consist of antibiotics and alternative treatments, utilized by different end users such as hospitals, home care settings, specialty clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The bacterial vaginosis market research report is one of a series of new reports from The Business Research Company that provides bacterial vaginosis market statistics, including the bacterial vaginosis industry's global market size, regional shares, competitors with a bacterial vaginosis market share, detailed bacterial vaginosis market segments, market trends and opportunities, and any further data you may need to thrive in the bacterial vaginosis industry. This bacterial vaginosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bacterial vaginosis market size has grown strongly in recent years. It will grow from $3.03 billion in 2024 to $3.31 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increase adoption of point-of-care diagnostics, growth of e-commerce, increase in risky sexual behaviors, rise in STI vaccination, and increase in healthcare access.

The bacterial vaginosis market size is expected to see strong growth in the next few years. It will grow to $4.71 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing prevalence of bacterial vaginosis, rising demand for functional foods, increasing incidence of STIs, increasing prevalence of women's health conditions, and rising awareness of menopause. Major trends in the forecast period include integration of artificial intelligence (AI) in diagnostics, adoption of probiotics, advancements in home-based STI testing, and adoption of sustainable materials in women's health devices.

The forecast of 9.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. women's health by driving up the cost of clindamycin vaginal creams and pH balance diagnostics sourced from Ireland and the Netherlands, exacerbating gynecological care costs and limiting treatment options. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of sexually transmitted infections (STIs) is expected to drive the growth of the bacterial vaginosis market. STIs are infections primarily transmitted through sexual contact and can be caused by bacteria, viruses, or parasites. Several factors contribute to the increasing prevalence of STIs, including unprotected sex, multiple partners, lack of awareness, and antibiotic resistance. Bacterial vaginosis increases vulnerability to STIs by disrupting the vaginal bacterial balance, making it easier for infections such as HIV and chlamydia to take hold. For example, in March 2024, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, reported a significant rise in STI cases in 2022 compared to the previous year, with gonorrhea increasing by 48%, syphilis by 34%, and chlamydia by 16%. As a result, the growing incidence of STIs is fueling the expansion of the bacterial vaginosis market.

Leading companies in the bacterial vaginosis market are developing innovative solutions such as multiplexed polymerase chain reaction (PCR) tests to accelerate diagnosis and treatment. A multiplexed PCR test enables the simultaneous amplification and detection of multiple target DNA or RNA sequences within a single experiment. For instance, in November 2022, Cepheid, a US-based biotechnology research company, launched the Xpert Xpress Multiplex Vaginal Panel (MVP). This test delivers rapid results in under 60 minutes and detects three vaginal infections bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV) from a single sample. Designed for both clinician-collected and self-collected swabs, the test utilizes automated real-time PCR technology to improve diagnostic accuracy and treatment outcomes. Its versatility allows for use in various clinical settings, ensuring efficient and precise detection of vaginal infections.

In July 2024, Evofem Biosciences, a US-based biopharmaceutical company, acquired the US commercial women's health specialty business from Lupin Limited for $84 million. This acquisition is intended to expand Evofem Biosciences' portfolio in women's health by adding an FDA-approved treatment for bacterial vaginosis and trichomoniasis. Lupin Limited, an India-based pharmaceutical company, specializes in the development and distribution of a wide range of healthcare products, including women's health specialty treatments.

Major players in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Merck KGaA, Bayer AG, Sanofi SA, Thermo Fisher Scientific, Becton Dickinson, Viatris Inc., Otsuka Pharmaceutical, LabCorp, Quest Diagnostics, Organon & Co., UT Southwestern Medical Center, Hologic Inc., bioMerieux SA, Shionogi & Company Limited, Melinta Therapeutics Inc., Evofem Biosciences, Gedea Biotech, Fleurstat, and Medical Diagnostic Laboratories.

North America was the largest region in the bacterial vaginosis market in 2024. The regions covered in bacterial vaginosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bacterial vaginosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bacterial vaginosis market includes revenues earned by entities by providing services such as wet mount microscopy, pH testing, and dietary recommendations. The market value includes the value of related goods sold by the service provider or included within the service offering. The bacterial vaginosis (BV) market consists of sales of oral and topical antibiotics, probiotics, pH balancers, gels, and creams. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bacterial Vaginosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bacterial vaginosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bacterial vaginosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bacterial vaginosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Point-Of-Care Testing; Laboratory Testing; Other Types
2) By Product: Below 15 Years; Between 15-45; Other Products
3) By Application: Antibiotics; Other Applications
4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End Users
Subsegments:
1) By Point-Of-Care Testing: Rapid Diagnostic Tests; Microscopy-based Tests; Immunoassays
2) By Laboratory Testing: Gram Staining; Polymerase Chain Reaction (PCR); DNA Probe Tests; Culture-based Testing
3) By Other Types: Home Testing Kits; Enzyme-linked Immunosorbent Assay (ELISA)
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Merck KGaA; Bayer AG; Sanofi SA; Thermo Fisher Scientific; Becton Dickinson; Viatris Inc.; Otsuka Pharmaceutical; LabCorp; Quest Diagnostics; Organon & Co.; UT Southwestern Medical Center; Hologic Inc.; bioMerieux SA; Shionogi & Company Limited; Melinta Therapeutics Inc.; Evofem Biosciences; Gedea Biotech; Fleurstat; Medical Diagnostic Laboratories
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r33976u

1. Executive Summary

2. Bacterial Vaginosis Market Characteristics

3. Bacterial Vaginosis Market Trends And Strategies

4. Bacterial Vaginosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Bacterial Vaginosis Growth Analysis And Strategic Analysis Framework

5.1. Global Bacterial Vaginosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bacterial Vaginosis Market Growth Rate Analysis
5.4. Global Bacterial Vaginosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bacterial Vaginosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bacterial Vaginosis Total Addressable Market (TAM)

6. Bacterial Vaginosis Market Segmentation

6.1. Global Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Point-Of-Care Testing
Laboratory Testing
Other Types
6.2. Global Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Below 15 Years
Between 15-45
Above 44 Years
Pregnant Women
Other Products
6.3. Global Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibiotics
Other Applications
6.4. Global Bacterial Vaginosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End Users
6.5. Global Bacterial Vaginosis Market, Sub-Segmentation Of Point-Of-Care Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rapid Diagnostic Tests
Microscopy-based Tests
Immunoassays
6.6. Global Bacterial Vaginosis Market, Sub-Segmentation Of Laboratory Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gram Staining
Polymerase Chain Reaction (PCR)
DNA Probe Tests
Culture-based Testing
6.7. Global Bacterial Vaginosis Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Home Testing Kits
Enzyme-linked Immunosorbent Assay (ELISA)

7. Bacterial Vaginosis Market Regional And Country Analysis

7.1. Global Bacterial Vaginosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bacterial Vaginosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bacterial Vaginosis Market

8.1. Asia-Pacific Bacterial Vaginosis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bacterial Vaginosis Market

9.1. China Bacterial Vaginosis Market Overview
9.2. China Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bacterial Vaginosis Market

10.1. India Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bacterial Vaginosis Market

11.1. Japan Bacterial Vaginosis Market Overview
11.2. Japan Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bacterial Vaginosis Market

12.1. Australia Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bacterial Vaginosis Market

13.1. Indonesia Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bacterial Vaginosis Market

14.1. South Korea Bacterial Vaginosis Market Overview
14.2. South Korea Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bacterial Vaginosis Market

15.1. Western Europe Bacterial Vaginosis Market Overview
15.2. Western Europe Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bacterial Vaginosis Market

16.1. UK Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bacterial Vaginosis Market

17.1. Germany Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bacterial Vaginosis Market

18.1. France Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bacterial Vaginosis Market

19.1. Italy Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bacterial Vaginosis Market

20.1. Spain Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bacterial Vaginosis Market

21.1. Eastern Europe Bacterial Vaginosis Market Overview
21.2. Eastern Europe Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bacterial Vaginosis Market

22.1. Russia Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bacterial Vaginosis Market

23.1. North America Bacterial Vaginosis Market Overview
23.2. North America Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bacterial Vaginosis Market

24.1. USA Bacterial Vaginosis Market Overview
24.2. USA Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bacterial Vaginosis Market

25.1. Canada Bacterial Vaginosis Market Overview
25.2. Canada Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bacterial Vaginosis Market

26.1. South America Bacterial Vaginosis Market Overview
26.2. South America Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bacterial Vaginosis Market

27.1. Brazil Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bacterial Vaginosis Market

28.1. Middle East Bacterial Vaginosis Market Overview
28.2. Middle East Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bacterial Vaginosis Market

29.1. Africa Bacterial Vaginosis Market Overview
29.2. Africa Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bacterial Vaginosis Market Competitive Landscape And Company Profiles

30.1. Bacterial Vaginosis Market Competitive Landscape
30.2. Bacterial Vaginosis Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Bacterial Vaginosis Market Other Major And Innovative Companies

31.1. Thermo Fisher Scientific
31.2. Becton Dickinson
31.3. Viatris Inc.
31.4. Otsuka Pharmaceutical
31.5. LabCorp
31.6. Quest Diagnostics
31.7. Organon & Co.
31.8. UT Southwestern Medical Center
31.9. Hologic Inc.
31.10. bioMerieux SA
31.11. Shionogi & Company Limited
31.12. Melinta Therapeutics Inc.
31.13. Evofem Biosciences
31.14. Gedea Biotech
31.15. Fleurstat

32. Global Bacterial Vaginosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bacterial Vaginosis Market

34. Recent Developments In The Bacterial Vaginosis Market

35. Bacterial Vaginosis Market High Potential Countries, Segments and Strategies

35.1 Bacterial Vaginosis Market In 2029 - Countries Offering Most New Opportunities
35.2 Bacterial Vaginosis Market In 2029 - Segments Offering Most New Opportunities
35.3 Bacterial Vaginosis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer